| Mark Phillip Moniz, MD | |
|
120 Kings Way Ste 2600, Williamsburg, VA 23185-2554 | |
| (757) 345-0141 | |
| (757) 206-1291 |
| Full Name | Mark Phillip Moniz |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 31 Years |
| Location | 120 Kings Way Ste 2600, Williamsburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528067014 | NPI | - | NPPES |
| 007311885 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 0101058407 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Doctors' Hospital Of Williamsburg | Williamsburg, VA | Hospital |
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Physician Services Inc | 5092608448 | 743 |
News Archive
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
The global COVID-19 pandemic has hit the United Kingdom hard. Collectively England, Scotland, Wales, and Northern Ireland now have the highest death toll in Europe, surpassing that of Spain, Italy, and France. The number of reported daily cases and deaths is still significant, as is the load on the healthcare system. As of now, the illness has affected almost 266,000 people in the UK, with over 37,000 deaths so far.
Primary care is "first-contact, continuous, comprehensive, and coordinated care provided to populations undifferentiated by gender, disease, or organ system.
Before they excise a tumor, surgeons need to determine exactly where the cancerous cells lie. Now, research published today in The Optical Society's (OSA) journal Optics Letters details a new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real time in the operating room.
For the second year in a row, BioTrends Research Group, Inc. has been ranked as one of the fastest-growing, privately-held companies in the Philadelphia region by the Philadelphia 100, a joint project of the Wharton Small Business Development Center, the Entrepreneurs' Forum of Greater Philadelphia, and the Philadelphia Business Journal.
› Verified 8 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
The global COVID-19 pandemic has hit the United Kingdom hard. Collectively England, Scotland, Wales, and Northern Ireland now have the highest death toll in Europe, surpassing that of Spain, Italy, and France. The number of reported daily cases and deaths is still significant, as is the load on the healthcare system. As of now, the illness has affected almost 266,000 people in the UK, with over 37,000 deaths so far.
Primary care is "first-contact, continuous, comprehensive, and coordinated care provided to populations undifferentiated by gender, disease, or organ system.
Before they excise a tumor, surgeons need to determine exactly where the cancerous cells lie. Now, research published today in The Optical Society's (OSA) journal Optics Letters details a new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real time in the operating room.
For the second year in a row, BioTrends Research Group, Inc. has been ranked as one of the fastest-growing, privately-held companies in the Philadelphia region by the Philadelphia 100, a joint project of the Wharton Small Business Development Center, the Entrepreneurs' Forum of Greater Philadelphia, and the Philadelphia Business Journal.
› Verified 8 days ago
| Entity Name | Urgent Specialty Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487164604 PECOS PAC ID: 7618235995 Enrollment ID: O20171213003293 |
News Archive
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
The global COVID-19 pandemic has hit the United Kingdom hard. Collectively England, Scotland, Wales, and Northern Ireland now have the highest death toll in Europe, surpassing that of Spain, Italy, and France. The number of reported daily cases and deaths is still significant, as is the load on the healthcare system. As of now, the illness has affected almost 266,000 people in the UK, with over 37,000 deaths so far.
Primary care is "first-contact, continuous, comprehensive, and coordinated care provided to populations undifferentiated by gender, disease, or organ system.
Before they excise a tumor, surgeons need to determine exactly where the cancerous cells lie. Now, research published today in The Optical Society's (OSA) journal Optics Letters details a new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real time in the operating room.
For the second year in a row, BioTrends Research Group, Inc. has been ranked as one of the fastest-growing, privately-held companies in the Philadelphia region by the Philadelphia 100, a joint project of the Wharton Small Business Development Center, the Entrepreneurs' Forum of Greater Philadelphia, and the Philadelphia Business Journal.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Phillip Moniz, MD 856 J Clyde Morris Blvd Ste A, Newport News, VA 23601-1318 Ph: (757) 316-5800 | Mark Phillip Moniz, MD 120 Kings Way Ste 2600, Williamsburg, VA 23185-2554 Ph: (757) 345-0141 |
News Archive
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
The global COVID-19 pandemic has hit the United Kingdom hard. Collectively England, Scotland, Wales, and Northern Ireland now have the highest death toll in Europe, surpassing that of Spain, Italy, and France. The number of reported daily cases and deaths is still significant, as is the load on the healthcare system. As of now, the illness has affected almost 266,000 people in the UK, with over 37,000 deaths so far.
Primary care is "first-contact, continuous, comprehensive, and coordinated care provided to populations undifferentiated by gender, disease, or organ system.
Before they excise a tumor, surgeons need to determine exactly where the cancerous cells lie. Now, research published today in The Optical Society's (OSA) journal Optics Letters details a new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real time in the operating room.
For the second year in a row, BioTrends Research Group, Inc. has been ranked as one of the fastest-growing, privately-held companies in the Philadelphia region by the Philadelphia 100, a joint project of the Wharton Small Business Development Center, the Entrepreneurs' Forum of Greater Philadelphia, and the Philadelphia Business Journal.
› Verified 8 days ago
James R Daniels Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Sentara Cir Ste 202, Williamsburg, VA 23188 Phone: 757-984-9850 | |
Michael E Landis, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 Sentara Cir Ste 350, Williamsburg, VA 23188 Phone: 757-736-7250 Fax: 757-510-9122 | |
Dr. Russell Witter Campbell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 156 Strawberry Plains Rd, Suite A, Williamsburg, VA 23188 Phone: 757-229-7939 Fax: 757-229-7897 | |
Dr. Hall Renfro Howard, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 120 Kings Way, Williamsburg, VA 23185 Phone: 757-345-0141 Fax: 757-253-1527 | |
Dr. Harry Lee Kraus Jr., MD Surgery Medicare: Medicare Enrolled Practice Location: 120 Kings Way, Suite 2600, Williamsburg, VA 23185 Phone: 757-345-0141 Fax: 757-253-1527 | |
Dr. Rebecca L Lofgren, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Sentara Cir, Ste 202, Williamsburg, VA 23188 Phone: 757-984-9850 Fax: 757-345-6643 |